comparemela.com
  1. Home
  2. Live Updates
  3. MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients : comparemela.com

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

,David Urso ,Richard Ghalie ,Linkedin ,Pharma Inc ,Academic Gi Cancer Consortium ,Nasdaq ,Clinical Study Protocol ,Bevacizumab Combination ,Initial Safety ,Initial Efficacy ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.